20
Curia Spain Sau, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their notable products is DORZOLAMIDE HYDROCHLORIDE, with a corresponding US DMF Number 18385.
Remarkably, this DMF maintains an Active status since its submission on May 31, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 21, 2013, and payment made on September 11, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II